On the evening of September 2, Kendley announced that the controlling shareholder of the company, Shanghai Kendley Holding Group Co., Ltd. and Changsha Wuzi Medical Investment Co., Ltd. signed a “Share Transfer Agreement” on September 1 to transfer the company's 21.8395 million unrestricted tradable shares to Changsha Weizhan at a price of 10.81 yuan per share, with a total transfer price of 236 million yuan. The purpose of the transfer of this agreement is to further deepen the strategic layout of the Kendry Group. For the company, the implementation of this strategy will obtain industrial and resource collaboration from strategic parties, expand development space in the consumer medical field, optimize the equity structure, and enhance corporate governance.

Zhitongcaijing · 09/02/2025 10:41
On the evening of September 2, Kendley announced that the controlling shareholder of the company, Shanghai Kendley Holding Group Co., Ltd. and Changsha Wuzi Medical Investment Co., Ltd. signed a “Share Transfer Agreement” on September 1 to transfer the company's 21.8395 million unrestricted tradable shares to Changsha Weizhan at a price of 10.81 yuan per share, with a total transfer price of 236 million yuan. The purpose of the transfer of this agreement is to further deepen the strategic layout of the Kendry Group. For the company, the implementation of this strategy will obtain industrial and resource collaboration from strategic parties, expand development space in the consumer medical field, optimize the equity structure, and enhance corporate governance.